Cluster for Individualized Immune Intervention (Ci3)
Cluster für Individualisierte ImmunIntervention

Project name

Project 1. Permides: It is the aim of PERMIDES to strengthen the competitiveness and foster the innovation potential of personalized medicine as an emerging industry in Europe by providing key solutions for the reconfiguration of the biopharmaceutical value chain towards a Health Economy 4.0 with a special focus on oncology (i.e. cancer treatment). Current value chain challenges lie in e.g. data gathering and exchange, big data and machine learning, or new software-based marketing methods. Via a cross-clustering approach, leading biopharma and IT clusters from three countries (Austria, Germany, and Norway) will create novel cross-sectoral collaborations between SMEs to address innovation barriers in the biopharma sector via cutting-edge IT solutions. As a cross-cutting industry, the ICT and software sector is an enabler of innovation in many industries and therefore provides a broad knowledge base of processes and best practice solutions in diverse industrial contexts and business environments.

Project 2. Digi-B-Cube (Digital Enterprise Innovations for Bioimaging, Biosensing and Biobanking Industries) The DIGI-B-CUBE project aims to unlock the cross-sectoral collaborative potential of SMEs by combining artificial intelligence (AI) and cognitive computing digital technologies (CCDT) with the bioimaging-biosensing-biobanking (B-CUBE) industries to deliver market sensitive disruptive technologies, and by generating innovative solutions that enhance patient-centred diagnostic work-flows, delivered through the improved algorithms for the efficiency and accuracy of medical diagnostics. DIGI-B-CUBE will study the characteristics in market dynamics & specificities for innovations created by merging AI, CCDT & B-CUBE industries. By providing a framework for a more structured cross-sectoral and cross-border collaboration that manages all of the complex workflows within the process, DIGI-B- CUBE instantiates the mechanisms to ensure long-term sustainability of the action through collaborations of the participating clusters with hospitals, academia, industry, investors, business angels, managing authorities of the national innovation agencies, and the European Commission support measures (such as EIT, ESIF). The main objective of this project is to provide key digital solutions for the reconfiguration of the medical diagnostics value chain towards a Health Economy 4.0 with a special focus on the biobanking, bioimaging and biosensing industries. Activities financed by the ESIF in the participating regions as part of the Smart Specialisation Strategies will be bundled in cooperation with the responsible managing authorities in addition to the innovation voucher scheme for SMEs. By integrating innovations in IT into bioimaging, biosensing and biobanking industries, this project will accelerate the goal of personalised medicine that can eventually offer patients a fast and efficient diagnosis-treatment-healthcare system.